Dr Reddy's launches generic anti-bacterial drug in US
The company's product is a therapeutic generic equivalent of Oracea capsules (40 mg) approved by the US Food and Drug Administration (USFDA).
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news